𝔖 Bobbio Scriptorium
✦   LIBER   ✦

85 Development of (−)-β-D-2,6-diaminopurine dioxolane as a potential antiviral agent: R. F. Schinazi,1∗ H. M. McClure,2 F. D. Boudinot,3 Y. Jxiang,3 and C. K. Chu.3 VA Medical Center/Emory University, Decatur, GA 30033;1 Yerkes Regional Primate Research Center/Emory University, Atlanta, GA 30322;2 and Department of Med. Chem. and Pharmacognosy, College of Pharmacy, Univ. of Georgia, Athens, GA 30602, USA3

Book ID
118393530
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
76 KB
Volume
23
Category
Article
ISSN
0166-3542

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of (-)-2′,3′-dideoxy-5-
Pharmacokinetics of (-)-2′,3′-dideoxy-5-fluoro-3′-thiacytidine [(-)-FTC] and its metabolites in rhesus monkeys: L. E. Moore1, L. Ni1, F. D. Boudinot1, H. M. McClure2, and R. F. Schinazi2,3,4 1College of Pharmacy, University of Georgia, Athens, Georgia 30602; 2Yerkes Regional Primate Research Center, and 3Department of Pediatrics, Emory University School of Medicine, Emory University, Atlanta, Georgia 30322; and 4Georgia Research Center for AIDS and HIV Infections, Veterans Affairs Medical Center, Decatur, Georgia, 30033, USA
📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 110 KB
Pharmacokinetics of dioxolane guanine (D
Pharmacokinetics of dioxolane guanine (DXG) following administration of DXG and prodrug, (-)-β-D-2,6-diaminopurine dioxolane (DAPD), to rats: H. Chen1, F. D. Boudinot1, A. Tang1, Z. Gao1, R. F. Schinazi2, and C. K. Chu1. 1College of Pharmacy, University of Georgia, Athens, GA 30602; and 2Emory University School of Medicine, Emory University, Atlanta, Georgia 30322 and Georgia Research Center for AIDS and HIV Infections, Veterans Affairs Medical Center, Decatur, Georgia, 30033, USA
📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 108 KB
153 Brain delivery of 2′-F-ara-ddl by ut
153 Brain delivery of 2′-F-ara-ddl by utilizing xanthine oxidase biotransformation system: C.K. Chu∗1, T. Koudriakova1, K. Shanmuganathan1, L. Ni2, F.D. Boudinot2, J.M. Gallo2, and R.F. Schinazi3. 1Department of Medicinal Chemistry and 2Department of Pharmaceutics, College of Pharmacy, University of Georgia, Athens, GA 30602, and 3Emory University School of Medicine/VA Medical Center, Atlanta, GA 30033
📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 45 KB
96 Characterization of human immunodefic
96 Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides: R. F. Schinazi,1∗ R. M. Lloyd, jr.,1 M.-H. Nguyen,2 D. Cannon,1 N. Ilksoy,1 C. K. Chu,3 D. C. Liotta,1 and J. W. Mellors.2 V A Medical Center/Emory University, Decatur, GA 30033;1 VA Medical Center/Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15261;2 and Department of Med. Chem. and Pharmacognosy, College of Pharmacy, Univ. of Georgia, Athens, GA 30602, USA3
📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 52 KB
Antiviral resistance to enantiomers of 2
Antiviral resistance to enantiomers of 2′,3′-dideoxycytidine analogues — Common threads: R. F. Schinazi,1* R. M. Lloyd, Jr.,1 A. McMillan,1 G. Gosselin,2, J.-L. Imbach,2 C.K. Chu,3, and J.-P. Sommadossi.4 VA Medical Center/Emory University, Decatur, GA 30033;1 University of Montpellier II, 34095 Montpellier, France,2 Dept. of Medicinal Chemistry, College of Pharmacy, University Georgia, Athens, GA 30602,3 and University of Alabama, Birmingham, AL 35294,4 USA
📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 71 KB
Multiple drug effect analyses with confi
Multiple drug effect analyses with confidence intervals for the evaluation of interactions of combined antiviral agents against hepatitis B virus: R.F. Schinazi,1* B. E. Korba,2 M. Belen'kii,1 C. K Chu,3 and J. D. Gangemi.4 Dept. of Pediatrics, VA Medical Center/Emory University, Decatur, GA 30033;1 DMVI, Georgetown University, Rockville MD 20852,2 Dept. of Medicinal Chem., College of Pharmacy, University Georgia, Athens, GA 30602,3 and Greenville Hospital System, Clemson University, Clemson, SC 29634,4 USA
📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 40 KB